Skip to content
Analysis of Orphan Drugs P&R criteria in Spain (2003-2019)
Home/Articles/Analysis of Orphan Drugs P&R criteria in Spain (2003-2019)
Analysis of Orphan Drugs P&R criteria in Spain (2003-2019)
Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019